
Yogamet-GMP 1 Tablet ER
Marketer
HiGlance Laboratories
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Yogamet-GMP 1 Tablet ER
Diabetol-XR 1mg Extended Release is a dual-action medication designed to manage blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin utilization, resulting in reduced blood sugar. Diabetol-XR 1mg ER should be administered precisely as directed by your physician. Ingestion with food is recommended to minimize gastrointestinal discomfort. Missed doses should be taken as soon as remembered, unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Baseline kidney function tests will be performed before treatment initiation. Limit alcohol consumption during treatment, as it may heighten the risk of side effects.
Primary Ingredients of Yogamet-GMP 1 Tablet ER
The provided text is "undefined," so no rephrasing is possible.
Uses of Yogamet-GMP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Yogamet-GMP 1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take Yogamet-GMP 1 Tablet ER with a meal.
Common Side effects of Yogamet-GMP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Yogamet-GMP 1 Tablet ER:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. It is recommended to take Yogamet-GMP 1 Tablet ER with food.
How Yogamet-GMP 1 Tablet ER works:
Yogamet-GMP 1 Tablet ER unites three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to optimize blood sugar management when monotherapy or dual regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Yogamet-GMP 1 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Yogamet-GMP tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Yogamet-GMP tablets (1mg) likely pose a breastfeeding safety risk. Available human data indicates potential transfer to breast milk, with possible infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Yogamet-GMP 1 Tablet ER, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Yogamet-GMP 1 Tablet ER. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with hepatic impairment should use Yogamet-GMP 1 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Yogamet-GMP 1 Tablet ER is contraindicated in individuals with severe liver disease.
What if you forget to take Yogamet-GMP 1 Tablet ER :
Should you forget to take a Yogamet-GMP 1 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Yogamet-GMP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
